Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MedImmune licenses RSV antibodies in $338M deal
MedImmune licenses RSV antibodies in $338M deal
MedImmune licenses RSV antibodies in $338M deal
Submitted by
admin
on December 1, 2009 - 10:25am
Source:
Fierce Biotech
News Tags:
RSV
antibodies
MedImmune
liscensing
Trellis Biosciences
Headline:
MedImmune licenses RSV antibodies in $338M deal
Do Not Allow Advertisers to Use My Personal information
